Medall Healthcare recovers from the pandemic. But profits, innovation hold key to an IPO in 2024.
Image credit: Medall via Facebook
Synopsis
Medall was facing challenges much before Covid-19. The constant chatter and murmurs of a major investor’s exit had started to visibly affect the day-to-day operations at the company and that is when Raju Venkatraman, the then CEO, retired. Investor Peepul Capital’s Arjun Ananth stepped in to reorient the business.
Back in November 2019, as the winter was about to set in across India, Medall Healthcare had to swallow a bitter pill. The company’s founder and chief executive officer, Raju Venkatraman, had decided to hang his boots. Venkatraman, a serial entrepreneur, had started the company in 2009 after buying Precision Diagnostics and he led the company to become one of the top five diagnostics service providers in the country at present.So, what
India
Raju-venkatraman
Medall-healthcare
Precision-diagnostics
Peepul-capital
Lal-pathlabs
Thyrocare
Health-care
இந்தியா
ராஜு-வெங்கட்ராமன்
பதக்கம்-சுகாதாரம்